We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A California lawmaker introduced a bill that would prohibit pharmaceutical companies from issuing certain prescription drug discounts or coupons to consumers in the state. Read More
The FDA will have to create a task force to identify regulations to repeal or modify under an executive order signed by President Trump last week. Read More
The Maryland General Assembly is considering two bills that would require pharmaceutical companies to notify the state ahead of drug price increases. Read More
India’s Ministry of Health is proposing that drug regulators and drugmakers implement several measures to improve the quality of drugs in the country’s supply chain, following a government estimate that 10 percent of them are substandard. Read More
The EMA identified ways to address the drawbacks of using electronic healthcare records and real-world evidence to support drug development and regulatory decision-making. Read More